Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women

Journal of Internal Medicine

Volumn 247, Issue 2, 2000, Pages 198-204

  Walker, Brian R ^a   Soderberg, S ^b   Lindahl, B ^b   Olsson, T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Glucocorticoids; Insulin resistance; Obesity

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CUSHING SYNDROME; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INSULIN RESISTANCE; MALE; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYDROCORTISONE; INSULIN; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SWEDEN; TRIGLYCERIDES;

EID: 0033966567     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00609.x     Document Type: Article

References (20)

1. 1 Walker BR, Best R, Shackleton DHL., Padfield PL, Edwards CRW. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 1996; 27: 190-96.
2. 2 Walker BR, Stewart PM, Shackleton CHL, Padfield PL, Edwards CRW. Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol (Oxf) 1993; 39: 221-27.
3. 3 Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R. Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension 1995; 25: 67-70.
4. 4 Walker BR, Phillips DIW, Noon JP et al. increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension 1998; 31: 891-95.
5. 5 Phillips DIW, Barker DJP, Fall CHD et al. Elevated plasma cortisol concentrations: an explanation for the relationship between low birthweight and adult cardiovascular risk factors. J Clin Endocrinol Metab 1998; 83: 757-60.
6. 6 Stolk RP, Lamberts SWJ, de Jong FH. Pols HAP, Grobbee DE. Gender differences in the associations between cortisol and insulin sensitivity in healthy subjects. J Endocrinol 1996; 149: 313-18.
7. 7 Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 1996; 14: 229-35.
8. 8 Ljung T, Andersson B, Bengtsson B, Bjorntorp P. Marin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obesity Research 1996; 4: 277-82.
9. 9 Hautanen A, Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med 1993; 234: 461-69.
10. 10 Pasquali R, Cantobelli S. Casimirri F et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993; 77: 341-46.
11. 11 Marin P, Darin M, Amemiya T, Andersson B. Jern S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992; 41: 882-86.
12. 12 Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and haemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83: 1853-59.
13. 13 Strain GW, Zumoff B, Kream J, Strain JJ. Levin J, Fukushima D. Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol. Metabolism 1982; 31: 209-12.
14. 14 Soderberg S, Olsson T, Eliasson M, Johnson O. Ahren B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 1999; 245: 533-43.
15. 15 Whitworth JA, Stewart PM, Burt D, Atherden SM, Edwards CRW. The kidney is the major site of cortisone production in man. Clin Endocrinol (Oxf) 1989; 31: 355-61.
16. 16 Andrew R, Phillips DIW, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 1998; 83: 1806-809.
17. 17 Korbonits M, Trainer PJ, Nelson ML et al. Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. Clin Endocrinol 1996; 45: 699-706.
18. 18 Pasquali R, Anconetani B, Chattat R et al. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomie nervous system in women with visceral and subcutaneous obesity: effects of the corticotrophin-releasing factor/arginine-vasopressin test and of stress. Metab Clin Exper 1996; 45: 351-56.
19. 19 Stewart PM, Shackleton CHL, Beastall GH, Edwards CRW. 5alpha-reductase activity in polycystic ovarian syndrome. Lancet 1990; 335: 431-33.
20. 20 Rodin A, Thakkar H, Taylor N, Clayton R. Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11beta-hydroxysteroid dehydrogenase. N Engl J Med 1994; 330: 460-65.